1. Influence of ABCB1 C3435T and ABCG2 C421A gene polymorphisms in response to imatinib mesylate in chronic myeloid leukemia patients;Au;Int. Con Cl Gr En.,2012
2. Association of genotypes and haplotypes of multi-drug transporter genes ABCB1 and ABCG2 with clinical response to imatinib mesylate in chronic myeloid leukemia patients;Au;Biomed. Pharmacother.,2014
3. Phytohemagglutinin-induced peripheral blood cytogenetics: a valid means for diagnosis and imatinib therapy monitoring of chronic phase chronic myeloid leukemia patients;Azad;J. Cancer Sci. Ther.,2015
4. Analysis of ABL kinase domain mutations as a probable cause of imatinib resistance in Chronic Myeloid Leukemia patients of Kashmir;Azad;Meta,2018
5. European Leukaemia Net recommendations for the management of chronic myeloid leukaemia;Baccarani;Blood,2013